← Evidence map

ReviewGynecologic oncology2022

Looking beyond carboplatin and paclitaxel for the treatment of advanced/recurrent endometrial cancer.

Maria Rubinstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36280455